These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8997563)

  • 1. Activity of trimethoprim/sulfamethoxazole plus polymyxin B against multiresistant Stenotrophomonas maltophilia.
    Muñoz JL; García MI; Muñoz S; Leal S; Fajardo M; Garćia-Rodríguez JA
    Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):879-82. PubMed ID: 8997563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C; Ni W; Cai X; Zhao J; Cui J
    PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
    Wu RX; Yu CM; Hsu ST; Wang CH
    J Microbiol Immunol Infect; 2022 Feb; 55(1):107-113. PubMed ID: 33500210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
    Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
    J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.
    Close SJ; McBurney CR; Garvin CG; Chen DC; Martin SJ
    Pharmacotherapy; 2002 Aug; 22(8):983-9. PubMed ID: 12173801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
    Poulos CD; Matsumura SO; Willey BM; Low DE; McGeer A
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2220-3. PubMed ID: 8619571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.
    Penzak SR; Abate BJ
    Pharmacotherapy; 1997; 17(2):293-301. PubMed ID: 9085321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
    Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
    Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.
    Rosenblatt JE; Stewart PR
    Antimicrob Agents Chemother; 1974 Jul; 6(1):84-92. PubMed ID: 15828175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Class 1 Integrons, sul1 and sul2 Genes Among Clinical Isolates of Stenotrophomonas maltophilia from a Tertiary Care Hospital in North India.
    Kaur P; Gautam V; Tewari R
    Microb Drug Resist; 2015 Aug; 21(4):380-5. PubMed ID: 25781206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial and antibiofilm activities of chlorogenic acid against clinical isolates of Stenotrophomonas maltophilia including the trimethoprim/sulfamethoxazole resistant strain.
    Karunanidhi A; Thomas R; van Belkum A; Neela V
    Biomed Res Int; 2013; 2013():392058. PubMed ID: 23509719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.
    Zelenitsky SA; Iacovides H; Ariano RE; Harding GK
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):39-43. PubMed ID: 15629227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysorbate 80 and polymyxin B inhibit Stenotrophomonas maltophilia biofilm.
    Malinowski AM; McClarty BM; Robinson C; Spear W; Sanchez M; Sparkes TC; Brooke JS
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):154-156. PubMed ID: 27923523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
    Traub WH; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes.
    Toleman MA; Bennett PM; Bennett DM; Jones RN; Walsh TR
    Emerg Infect Dis; 2007 Apr; 13(4):559-65. PubMed ID: 17553270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives.
    Rizek C; Ferraz JR; van der Heijden IM; Giudice M; Mostachio AK; Paez J; Carrilho C; Levin AS; Costa SF
    J Infect Chemother; 2015 Feb; 21(2):114-7. PubMed ID: 25456893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.